Research location
West Bloomfield
Michigan, United States
Advertisement
Research activity in West Bloomfield
Michigan, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 144 trials and 144 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in West Bloomfield
144 linked trials · page 2 of 3Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate CancerNCT03697148 · 2019-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)NCT03781791 · 2018-12-10 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor FluctuationsNCT03670953 · 2018-11-06 · 1 site observation
COMPLETED
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant MesotheliomaNCT03228537 · 2018-07-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate a New Treatment in Patients With Parkinson's DiseaseNCT03407378 · 2018-06-26 · 1 site observation
COMPLETED
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE TrialNCT03371719 · 2018-06-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerNCT03414970 · 2018-03-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sNCT03329508 · 2018-01-19 · 1 site observation
COMPLETED
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or PlaceboNCT03281954 · 2017-12-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung CancerNCT03373760 · 2017-11-30 · 1 site observation
COMPLETED
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerNCT03233191 · 2017-09-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate CancerNCT03274687 · 2017-07-28 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's DiseaseNCT03100149 · 2017-06-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryNCT03188393 · 2017-04-13 · 1 site observation
COMPLETED
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryNCT03070886 · 2017-04-05 · 1 site observation
ACTIVE_NOT_RECRUITING
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) StudyNCT03152292 · 2017-03-30 · 1 site observation
TERMINATED
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung CancerNCT03377556 · 2017-03-03 · 1 site observation
COMPLETED
Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNCT02834013 · 2017-01-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerNCT02954874 · 2017-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyNCT02927249 · 2017-01-06 · 1 site observation
TERMINATED
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive SleepinessNCT03037203 · 2017-01-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease PsychosisNCT02969369 · 2016-12-31 · 1 site observation
COMPLETED
CPC-201 Alzheimer's Disease Type Dementia: PET StudyNCT02860065 · 2016-09-30 · 1 site observation
WITHDRAWN
Breast Cancer WEight Loss Study (BWEL Study)NCT02750826 · 2016-09-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesNCT02595905 · 2016-09-15 · 1 site observation
COMPLETED
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)NCT02595944 · 2016-07-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004NCT02615873 · 2016-07-01 · 1 site observation
UNKNOWN
Study of Urate Elevation in Parkinson's Disease, Phase 3NCT02642393 · 2016-06-01 · 1 site observation
COMPLETED
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)NCT02807675 · 2016-06-01 · 1 site observation
COMPLETED
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's DiseaseNCT02726386 · 2016-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's PatientsNCT02605434 · 2016-03-01 · 1 site observation
UNKNOWN
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic HypotensionNCT02586623 · 2016-02-11 · 1 site observation
COMPLETED
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersNCT02785952 · 2015-12-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung CancerNCT02635009 · 2015-12-22 · 1 site observation
COMPLETED
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseNCT02610231 · 2015-12-01 · 1 site observation
COMPLETED
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyNCT02445391 · 2015-10-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseNCT02542696 · 2015-08-31 · 1 site observation
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerNCT02488967 · 2015-07-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's PatientsNCT02453386 · 2015-07-01 · 1 site observation
TERMINATED
Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's DiseaseNCT02469090 · 2015-06-18 · 1 site observation
COMPLETED
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF EpisodesNCT02242487 · 2015-03-01 · 1 site observation
COMPLETED
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's DiseaseNCT02066571 · 2015-03-01 · 1 site observation
UNKNOWN
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Infusion of Apomorphine: Long-term Safety StudyNCT02339064 · 2015-02-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence RecoveryNCT02352103 · 2015-01-01 · 1 site observation
COMPLETED
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves SurvivalNCT02364557 · 2014-12-24 · 1 site observation
COMPLETED
Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF EpisodesNCT02240030 · 2014-11-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced DyskinesiaNCT02274766 · 2014-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.